Contents
Aetiology
Exogenous endophthalmitis:
Infecting organisms gain entry into the eye via direct inoculation
- Intraocular surgery
- Penetrating trauma
- Contiguous spread from adjacent tissues
Endogenous endophthalmitis:
Infectious agents hematogenously spread into the eye from a distant focus of infection
- Liver abscess (M/C)
Causative organisms:
- Staphylococcus epidermidis (30.3%)
- Other coagulase-negative Staphylococcus (9.1%)
- Streptococcus viridans (12.1%)
- Staphylococcus aureus (11.1%)
- Enterobacteriaceae (3.4%)
- Pseudomonas aeruginosa (2.5%)
- Klebsiella pneumoniae
Risk factors:
For endogenous endophthalmitis
- Chronic metabolic diseases:
- Diabetes (M/C)
- Immunosuppression
- Malignancy
- IV drug abuse
- Long-term presence of an intracorporeal foreign body
- Invasive surgery
Clinical features
Ocular symptoms:
- Ocular pain, redness, swelling, and discharge
- Blurred vision and floaters
Systemic symptoms:
often non-specific
- Malaise, nausea, loss of appetite or weight, abdominal discomfort, fever, chills, and rigor.
Complications
- Panophthalmitis: M/extensive ocular involvement in endophthalmitis with inflammation in periocular tissues.
- Corneal ulcer
- Orbital cellulitis
- Loss of vision
- Retinal detachment
Diagnosis
The diagnosis of endophthalmitis depends mostly on the clinical findings on ophthalmological examination. Delayed diagnosis of endogenous endophthalmitis can lead to not only visual loss, but also increased risk of mortality.
Differential diagnosis:
- Retinochoroidal infection
- Noninfectious posterior/intermediate uveitis
- Neoplastic conditions: Large cell lymphoma or retinoblastoma
Management
Antimicrobial therapy:
Owing to the rapid progression and poor prognosis of endophthalmitis, treatment should be started empirically without waiting for laboratory confirmation.
- Systemic broad-spectrum antibiotics + intravitreal injection of antibiotics (ceftazidime, 2.25 mg/0.1 mL; vancomycin, 1 mg/0.1 mL) or anti-fungal agents (amphotericin B, fluconazole, voriconazole).
Adjunctive therapy:
Ameliorate inflammation and pain as well as secondary glaucoma
- Topical cycloplegics
- Steroids
- Hypotensive agents
Pars plana vitrectomy (PPV):
Indicated for persistent inflammation, vitreous biopsy, or retinal complication